Rexulti 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FY8VJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,923
Award facts
- Contract value 100% obligated
- $14,922.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Rexulti 1 mg tablets (30-count units) with a contract value of $14,922.69 and a completion date of January 15, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which enables comprehensive global pharmaceutical support for military healthcare programs.
This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and broader military healthcare operations. AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) maintains significant pharmaceutical supply contracts across the federal government and regularly fulfills orders for brand-name and generic medications across multiple therapeutic domains. The firm fixed-price structure and short fulfillment timeline demonstrate the operational efficiency typical of established pharmaceutical prime vendors serving the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FY8VJ?
SPE2DR26FY8VJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FY8VJ worth?
The government has obligated $14,923 on SPE2DR26FY8VJ.
Is contract SPE2DR26FY8VJ an order under another contract?
Yes. SPE2DR26FY8VJ is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8VJ competed?
The extent of competition for SPE2DR26FY8VJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award